Holen Sie sich die Stockscreener-App
1.88
3.30%
0.06
Handel nachbörslich:
1.89
0.01
+0.53%
Inotiv Inc Aktie (NOTV) Neueste Nachrichten
Inotiv, Inc. (NASDAQ:NOTV) Position Boosted by Two Sigma Advisers LP - Defense World
NOTV 10-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Inotiv, Inc. (NOTV) Investors with Significant Losses to Contact Firm’s Attorneys Before Aug. 22nd Deadline in Securities Class Action - ACCESS Newswire
Millennium Management LLC Increases Stock Holdings in Inotiv, Inc. (NASDAQ:NOTV) - Defense World
Inotiv, Inc. (NASDAQ:NOTV) Shares Sold by Ameriprise Financial Inc. - Defense World
Inotiv at Jefferies Global Healthcare: Strategic Growth and Stability By Investing.com - Investing.com Canada
Inotiv at Jefferies Global Healthcare: Strategic Growth and Stability - Investing.com Australia
Inotiv says it was told US SEC has closed bribery probe tied to primate imports - MLex
Inotiv discloses completion of SEC investigation (NOTV:NASDAQ) - Seeking Alpha
sec concludes investigation into inotiv, no enforcement action planned By Investing.com - Investing.com South Africa
Inotiv Cleared by SEC in Importation Probe - TipRanks
Northern Trust Corp Acquires 8,134 Shares of Inotiv, Inc. (NASDAQ:NOTV) - Defense World
Inotiv (NOTV) Gets a Buy from Lake Street - The Globe and Mail
Jefferies raises Inotiv stock price target on revenue growth outlook By Investing.com - Investing.com South Africa
Jefferies raises Inotiv stock price target on revenue growth outlook - Investing.com Australia
Inotiv Hosts 2025 Investor Day, Highlights Strategic Plans - TipRanks
Lazard Asset Management LLC Sells 9,230 Shares of Inotiv, Inc. (NASDAQ:NOTV) - Defense World
Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025 - The Manila Times
Exclusive: Inotiv CEO Set for Strategic Update at Jefferies Healthcare Conference - Stock Titan
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inotiv, Inc. (NOTV) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Filed - ACCESS Newswire
Dimensional Fund Advisors LP Has $131,000 Stock Position in Inotiv, Inc. (NASDAQ:NOTV) - Defense World
Inotiv outlines revised RMS site optimization plan with $6.5M investment and $6M-$7M annual savings projection - MSN
Inotiv, Inc. (NASDAQ:NOTV) Q2 2025 Earnings Call Transcript - Insider Monkey
Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates - MSN
Inotiv, Inc. Earnings Call Highlights Revenue Growth - TipRanks
Inotiv (NOTV): Analyst Maintains Rating, Lowers Price Target | NOTV Stock News - GuruFocus
Inotiv quarterly loss narrows; site optimization efforts continue - Inside INdiana Business
Inotiv, Inc. SEC 10-Q Report - TradingView
Inotiv, Inc. Reports Improved Q2 Fiscal 2025 Results - TipRanks
Earnings call transcript: Inotiv Inc beats EPS forecast in Q2 2025 - Investing.com India
Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update - GlobeNewswire
Lake Street Sticks to Its Buy Rating for Inotiv (NOTV) - The Globe and Mail
Positive Sentiment Still Eludes Inotiv, Inc. (NASDAQ:NOTV) Following 29% Share Price Slump - simplywall.st
Inotiv, Inc. (NOTV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - MSN
Inotiv, Inc. (NASDAQ:NOTV) Shares Sold by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Health Check: How Prudently Does Inotiv (NASDAQ:NOTV) Use Debt? - simplywall.st
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025 - The Manila Times
Inotiv, Inc. to Release Fiscal 2025 Second Quarter Financial Results on May 7, 2025 - Nasdaq
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial - GlobeNewswire
Inotiv Sets Q2 Earnings Release Date: Key Financial Results Coming May 7 After Market Close - Stock Titan
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing - Benzinga
Inotiv (NOTV) Faces Significant Shareholder Losses - GuruFocus
Sea Pharmaceuticals Partners with Inotiv for Pre-Clinical Studies on SPM-0404 - GuruFocus
Inotiv (NOTV) Plummets 50% as FDA Shifts Away from Animal Testing | CRL Stock News - GuruFocus
NOTV Stock Hits 52-Week Low at $1.2 Amid Market Challenges - Investing.com
Inotiv director sells $12,915 in common stock By Investing.com - Investing.com South Africa
Inotiv director sells $12,915 in common stock - Investing.com
Inotiv shareholders approve expanded equity incentive plan By Investing.com - Investing.com Australia
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inotiv, Inc. (NOTV) Investors with Significant Losses to Contact the Firm’s Attorneys, Application Deadline Approaching in Securities Class Action - ACCESS Newswire
0.17%
2.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):